MEG3 and colorectal carcinoma: When it comes to comparing serum levels of the measured parameters within the CRC group between the obese and non-obese patients (Fig. 3), MEG3 levels were noticed to be profoundly lower in obese CRC compared to non-obese CRC patients (P < 0.0001).